Clinical Characteristics of Intravenous Pantoprazole Consumption in Cardiac Intensive Care Unit

Publish Year: 1400
نوع سند: مقاله ژورنالی
زبان: English
View: 58

This Paper With 8 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_PBRE-7-3_004

تاریخ نمایه سازی: 10 دی 1402

Abstract:

Background: Proton Pump Inhibitors (PPIs) are the most common medicine for the treatment and prophylaxis of acid peptic conditions. The inappropriate use of the PPIs, mainly the intravenous form of pantoprazole may lead to excessive cost and unexpected adverse effects.  Objectives: The present study aimed to evaluate the use of intravenous pantoprazole in the International Heart Center in the north of Iran. Methods: The current retrospective study was performed on ۲۱۵ patients hospitalized in Fatemeh Zahra Hospital in Sari City, Iran. Patients’ demographics, the type and doses of pantoprazole, and other relevant clinical data were recorded from their documentation. The appropriate use of pantoprazole was evaluated according to recommendations provided by Medscape ۲۰۲۰, and UpToDate ۲۰۲۰. Results: Prescribing PPI was appropriate for ۵۳.۵% of the examined patients; however, the majority of intravenous prescription cases were inappropriate (۷۶.۷%). Oral PPIs could have been used in ۹۳.۵% of the cases; however, they received the parenteral form of pantoprazole. The main cause of pantoprazole prescription in the explored hospital was stress ulcer prophylaxis, with the median ۴/۱۸ days used, which internal specialists in most of the cases (۴۵.۶%) prescribed. Conclusion: In the current study, administrating intravenous pantoprazole was inappropriate in most of the cases. As a result of this improper administration, the extensive cost is exposed to the healthcare system, i.e., likely to be unsafe for patients. Accordingly, risk and indication evaluation for the prescription of pantoprazole should be a priority in each patient. Finally, it seems necessary to determine a protocol for PPI prescription per hospital for the rational use of drugs.

Authors

Gohar Eslami

Department of Clinical Pharmacy, Cardiovascular Research Center, Mazandaran University of Medical Sciences, Sari, Iran.

Elahe Karimpour Razkenari

Department of Clinical Pharmacy, Faculty of Pharmacy, Mazandaran University of Medical Science, Sari, Iran.

Yahya Sharifi

Pharmaceutical Sciences Research Center, Hemoglobinopathy Institute, Department of Clinical Pharmacy, Faculty of Pharmacy, Sari, Iran.

Aria Soleimani

Department of Anesthesiology, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.

Ebrahim Salehifar

Department of Clinical Pharmacy, Pharmaceutical Research Center, Hemoglobinopathy Institute, Mazandaran University of Medical Sciences, Sari, Iran.

Parastoo Karimi Aliabadi

Department of Family Medicine, Diabetes Research Center, Mazandaran University of Medical Sciences, Sari, Iran.

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. ...
  • Chomsky N. What is special about language. SBS Lecture Series: ...
  • Moore T, Bykov A, Savelli T, Zagorski A. Guidelines for ...
  • Zacharias A, Schwann TA, Parenteau GL, Riordan CJ, Durham SJ, ...
  • Byhahn C, Strouhal U, Martens S, Mierdl S, Kessler P, ...
  • Hata M, Shiono M, Sekino H, Furukawa H, Sezai A, ...
  • Aljarallah B, Wong W, Modry D, Fedorak R. Prevalence and ...
  • Taylor PC, Loop FD, Hermann RE. Management of acute stress ...
  • BERKOWITZ D, WAGNER BM, URICCHIO JF. Acute peptic ulceration following ...
  • Ortoleva J, Bittner EA. Gastrointestinal Complications and Their Management After ...
  • Chaudhry R, Zaki J, Wegner R, Pednekar G, Tse A, ...
  • van der Voort PH, Zandstra DF. Pathogenesis, risk factors, and ...
  • Egleston C, Wood A, Gorey T, McGovern E. Gastrointestinal complications ...
  • Selkane C, Allah YM, Elbekkali Y, Amahzoune B, Wahid F, ...
  • Yoshida K, Matsumoto M, Sugita T, Nishizawa J, Matsuyama K, ...
  • Behrens R, Hofbeck M, Singer H, Scharf J, Rupprecht T. ...
  • Houssa MA, Atmani N, Nya F, Abdou A, Moutakiallah Y, ...
  • Pang SH, Graham DY. A clinical guide to using intravenous ...
  • Yang YX, Metz DC. Safety of proton pump inhibitor exposure. ...
  • Freedberg DE, Yang Y-X, Abrams JA. Proton pump inhibitors and ...
  • Zhu W, Hong K. Potential cardiovascular risks of proton pump ...
  • Ahmadi H, Ahangar N, Saghafi F, Ala S, Eslami G, ...
  • Sohrevardi S-M, Vahidi A, Mosadegh M-H, Dehghani-Tafti A, Dadollahi A. ...
  • Perwaiz MK, Posner G, Hammoudeh F, Schmidt F, Neupane N, ...
  • Chia CTW, Lim WP, Vu CKF. Inappropriate use of proton ...
  • Kaplan GG, Bates D, McDonald D, Panaccione R, Romagnuolo J. ...
  • George CJ, Korc B, Ross JS. Appropriate proton pump inhibitor ...
  • Gamelas V, Salvado V, Dias L. Prescription Pattern of Proton ...
  • Elnaem MH, Mohamed MHN, bin Nazar AH, binti Ibrahim RNK. ...
  • Moradi M, Raeesi S, Sepehri Z. Audit of IV pantoprazole: ...
  • Pinto‐Sanchez MI, Yuan Y, Bercik P, Moayyedi P. Proton pump ...
  • Savarino V, Dulbecco P, de Bortoli N, Ottonello A, Savarino ...
  • Naunton M, Peterson G, Deeks L, Young H, Kosari S. ...
  • Guda NM, Noonan M, Kreiner MJ, Partington S, Vakil N. ...
  • Molloy D, Molloy A, O’Loughlin C, Falconer M, Hennessy M. ...
  • Vazin A, Karimzadeh I, Karamikhah R, Oveisi Z, Mohseni S, ...
  • Freedberg DE, Salmasian H, Abrams JA, Green RA. Orders for ...
  • Sandig C, Flechtenmacher C, Stremmel W, Eisenbach C. Pantoprazole induces ...
  • Koury S, Stone C, La DC. Omeprazole and the development ...
  • Wolf MM. proton pump inhibitors:overview of use and adverse effects ...
  • Dylan ren. appropriate use and stewardship of proton-pump inhibitors. medscape, ...
  • نمایش کامل مراجع